188
Views
23
CrossRef citations to date
0
Altmetric
Review

Complementary medicine for depression

, &
Pages 1741-1751 | Published online: 09 Jan 2014

References

  • WHO. The ICD-10 Classification of Mental and Behavioural Disorders. World Health Organization, Geneva, Switzerland (1992).
  • Martinez C, Rietbrock S, Wise L et al. Antidepressant treatment and the risk of fatal and non-fatal self-harm in first episode depression. Br. Med. J.330, 389–393 (2005).
  • Fergusson D, Doucette S, Glass KC et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. Br. Med. J.330, 396–399 (2005).
  • Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry63, 332–339 (2006).
  • Berman BM. The Cochrane Collaboration and evidence-based complementary medicine. J. Altern. Complement. Med.3(2), 191–194 (1997).
  • Unutzer J, Klap R, Sturm R et al. Mental disorders and the use of the alternative medicine: results from a national survey. Am. J. Psychiatry157(11), 1851–1857 (2000).
  • Kessler RC, Soukup J, Davis RB et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am. J. Psychiatry158, 289–294 (2001).
  • Wang J, Patten SB, Russell ML. Alternative medicine use by individuals with major depression. Can. J. Psychiatry46, 528–533 (2001).
  • Wang J, Patten SB, Williams JV et al. Help-seeking behaviours of individuals with mood disorders. Can. J. Psychiatry50(10), 652–659 (2005).
  • Jorm AF, Griffiths KM, Christensen H, Parslow RA, Rogers B. Actions taken to cope with depression at different levels of severity: a community survey. Psychol. Med.34, 293–299 (2004).
  • Lewith G, Jonas WB, Walach H. The role of outcomes research in evaluating complementary and alternative medicine. In: Clinical Research in Complementary Therapies: Principles, Problems and Solutions. Churchill Livingstone, London, UK, 29–45 (2002).
  • Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture – a review. Complement Ther. Med.11(4), 235–242 (2003).
  • Kaptchuk TJ, Stason WB, Davis RB et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. Br. Med. J.332(7538), 391–397 (2006).
  • Smith CA, Hay PPJ. Acupuncture for depression. Cochrane Syst. Rev.3, CD004046 John Wiley and Sons.
  • Cummings M, Reid F. BMAS policy statements in some controversial areas of acupuncture practice. Acupunct. Med.22(3), 134–136 (2004).
  • MacPherson H, Thomas KJ, Walters S et al. The York acupuncture safety study: prospective survey of 34,000 treatments by traditional acupuncturists. Br. Med. J.323, 486–487 (2001).
  • White A, Hayoe S, Hart A et al. Adverse events following acupuncture: prospective survey of 32,000 consultations with doctors and physiotherapists. Br. Med. J.323, 485–486 (2001).
  • Macpherson H, Scullion A, Thomas KJ, Walters S. Patient reports of adverse events associated with acupuncture treatment: a prospective national survey. Qual. Saf. Health Care13, 349–355 (2004).
  • Han JS. Electroacupuncture: an alternative to antidepressants for treating affective diseases. Int. J. Neurosci.29, 79–92 (1986).
  • Mukaino Y, Park J, White A, Ernst E. The effectiveness of acupunture for depression – a systematic review of randomised controlled trials. Acupunct. Med.23(2), 70–76 (2005).
  • Tisserand R, Balacs T. Essential oil safety. Churchill Livingstone, NY, USA (1995)
  • Hallissey S. Aromatherapy and massage. In: Integrated Cancer Care. Barraclough J (Ed). Oxford University Press, Oxford, UK (2001).
  • Tiran D. Reviewing theories and origins. In: Clinical Reflexology: A Guide for Health Professionals. PA Mackereth, D Tiran (Eds). Churchill Livingstone, London, UK, 5–15 (2002).
  • Buckle J. ClinicaL Aromatherapy: Essential Oils in Practice. Second Edition. Churchill Livingstone, London, UK (2003).
  • Natural standard herb and supplement handbook: the clinical bottom line. Basch EM, Ulbricht CE (Eds). Mosby, St Louis, Missouri, USA (2005).
  • Ernst E. The safety of massage therapy. Rheumatology42(9), 1101–1106 (2003).
  • Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol. Bull.130(1), 3–18 (2004).
  • Taylor MJ, Carney S, Geddes J, Goodwin G. Folate for depressive disorders. Cochrane Syst. Rev.2, CD003390 (2003).
  • Taylor MJ, Wilder H, Bhagwagar Z, Geddes J. Inositol for depressive disorders. Cochrane Syst. Rev.1, CD004049 (2004).
  • Shaw K, Turner J, Del Mar C. Tryptophan and 5-Hydroxytryptophan for depression. Cochrane Syst. Rev.1, CD003198 (2002).
  • Schachter HM, Kourad K, Merali Z et al. Effects of omega-3 fatty acids on mental health. Evid. Rep. Technol. Assess.No. 116. AHRQ Publication No 05-E022–1.Agency for Healthcare Research and Quality, Rockville, MD, USA (2005).
  • Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol. Scand.154(Suppl.), 7–14 (1994).
  • Hardy ML, Coulter I, Morton SC et al. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Evid. Rep. Technol. Assess.64(Summ.), 1–3 (2003).
  • Williams AL, Girard C, Jui D, Sabina A, Katz DL. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clin. Invest. Med.28(3), 132–139 (2005).
  • Mills S, Bone K. Principles of herbal pharmacology. In: Principles and Practice of Phytotherapy: Modern Herbal Medicine. Churchill Livingston, London, UK, 22–79 (2000).
  • Natural Medicines Comprehensive Database. Fifth edition.Jellin JM, Gregory PJ (Eds). Therapeutic Research Faculty, Stockton, CA, USA (2003).
  • Calapai G, Crupi A, Firenzuoli F et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum.Pharmacopsychiatry34(2), 45–49 (2001).
  • Zanoli P. Role of hyperforin in the pharmacological activities of St. John’s Wort. CNS Drug Rev.10, 203–218 (2004).
  • Mennini T, Gobbi M. The antidepressant mechanism of Hypericum perforatum. Life Sci.75, 1021–1027 (2004).
  • Pilkington K, Boshnakova A, Richardson J. St John’s wort for depression: time for a different perspective? Complement. Ther. Med. (2006) (In Press).
  • Linde K, Mulrow CD, Berner M, Egger M. St John’s Wort for depression. Cochrane Syst. Rev.3, CD000448 (2005).
  • Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother. Res.19(2), 148–151 (2005).
  • Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complement. Altern. Med.4, 12 (2004).
  • Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J. Ethnopharmacol.97(2), 281–284 (2005).
  • Akhondzadeh S, Kashani L, Fotouhi A et al. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog. Neuropsychopharmacol. Biol. Psychiatry27(1), 123–127 (2003).
  • Freeman LW. Homeopathy: like cures like. In: Complementary and Alternative Medicine: An Evidence-based Approach. Mosby, MO, USA, 345–360 (2001).
  • Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homeopathy. Br. Med. J.302, 316–323 (1991).
  • Linde K, Clausius N, Ramirez G et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet350, 834–843 (1997).
  • Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical efficacy of homeopathy: a meta-analysis of clinical trials. Eur. J. Clin. Pharmacol.56, 27–33 (2000).
  • Shang A, Huwiler-Müntener K, Nartey L et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet366, 726–732 (2005).
  • Pilkington K, Kirkwood G, Rampes H, Fisher P, Richardson J. Homeopathy for depression: a systematic review of the research evidence. Homeopathy94, 153–163 (2005).
  • Canter PH. The therapeutic effects of meditation. (Editorial). Br. Med. J.326, 1049–1050 (2003).
  • Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Syst.Rev.1, CD004998 (2006).
  • Kabat-Zinn J. Bringing mindfulness to medicine. Interview by Karolyn A. Gazella. Altern. Ther. Health Med.11(3), 56–64 (2005).
  • Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis.J. Psychosom. Res.57(1), 35–43 (2004).
  • Teasdale J, Segal Z, Williams J, Ridgeway V, Soulsby J, Lau M. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J. Consult. Clin. Psychol.68, 615–623 (2000).
  • Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J. Consult. Clin. Psychol.72(1), 31–40 (2004).
  • Riley D. Hatha yoga and the treatment of illness (commentary). Altern. Ther. Health Med.10(2), 20–21 (2004).
  • Pilkington K, Kirkwood G, Rampes H, Richardson J. Yoga for depression: the research evidence. J. Affect. Disord.89(1–3), 13–24 (2005).
  • Sharma VK, Das S, Mondal S, Goswampi U, Gandhi A. Effect of Sahaj Yoga on depressive disorders. Indian J. Physiol. Pharmacol.49(4), 462–468 (2005).
  • Stetter F, Kupper S. Autogenic training: a meta-analysis of clinical outcome studies. Appl. Psychophysiol. Biofeedback27(1), 45–98 (2002).
  • Eller LS. Guided imagery interventions for symptom management. Annu. Rev. Nurs. Res.17, 57–84 (1999).
  • Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database of Systematic Reviews2, CD004050 (2004).
  • Jorm AF, Christensen H, Griffiths KM, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Med. J. Aust.176(Suppl.), S84–S96 (2002).
  • Kirsch I. The placebo effect in complementary medicine. In: Clinical Research in Complementary Therapies. Lewith G, Jonas W, Walach H (Eds). Churchill Livingstone, Edinburgh, UK, 129–137 (2002).
  • Shannon S. Synthesis. In: Handbook of Complementary and Alternative Therapies in Mental Health. Scott S (Ed.). Academic Press, London, UK, 541–557 (2002).

Websites

  • NICE. Depression: management of depression in primary and secondary care. Clinical Guideline 23. Developed by the National Collaborating Centre for Mental Health. National Institute for Clinical Excellence, London, UK (2004) http://nice.org.uk/CG023NICEguideline
  • WHO. Depression. World Health Organisation, Geneva (2006) www.who.int/mental_health/management/depression/definition/en/print.html
  • Cochrane Collaboration Complementary Medicine Field. University of Maryland. www.compmed.umm.edu/ Accessed Aug 2006
  • National Library for Health Specialist Library for Complementary and Alternative Medicine. National Library for Health. www.library.nhs.uk/cam Accessed Aug 2006
  • CAMEOL (Complementary and Alternative Medicine Evidence OnLine) database. Research Council for Complementary Medicine/University of Westminster. www.rccm.org.uk/cameol Accessed Aug 2006
  • NCCAM (National Centre for Complementary and Alternative Medicine). What is Complementary and Alternative Medicine (CAM)? Definitions. (2002). http://nccam.nih.gov/hralth/whatiscam/index.htmd1. Accessed 31 March 2006
  • Pilkington K, Kirkwood G, Rampes H, Richardson J. Aromatherapy and massage for depression: a systematic review. Complementary and Alternative Medicine Evidence Online (CAMEOL) Database. (2006) www.rccm.org.uk/cameol/Default.aspx Accessed 7 Apr 2006
  • Pilkington K, Kirkwood G, Rampes H, Richardson J. Reflexology for depression: a systematic review. Complementary and Alternative Medicine Evidence Online (CAMEOL) Database. (2006) www.rccm.org.uk/cameol/Default.aspx Accessed 7 Apr 2006
  • NCCAM . Mind-Body Medicine: An Overview. (2005) http://nccam.nih.gov/health/backgrounds/mindbody.htmskpnav Accessed 25 Aug 2005
  • Kirkwood G, Rampes H, Richardson J, Pilkington K. Meditation for depression: a systematic review. Complementary and Alternative Medicine Evidence Online (CAMEOL) Database (2005) www.rccm.org.uk/cameol/Default.aspx Accessed 7 Apr 2006
  • NCCAM (National Centre for Complementary and Alternative Medicine).National Institutes of Health. http://nccam.nih.gov/ Accessed Apr 2006
  • Depression Alliance. www.depressionalliance.org. Accessed Apr 2006
  • Prince of Wales’s Foundation for Integrated Health. Unity in Diversity: Complementary healthcare in mental health services www.fihealth.org.uk Accessed Apr 2006
  • BluePages Depression Information. The Centre for Mental Health Research, The Australian National University. http://bluepages.anu.edu.au/ Accessed 7 Apr 2006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.